C hanges in clinical technology and organizational capabilities permit an ever-increasing share of surgical and diagnostic procedures to be done as ambulatory rather than inpatient services. Hospitals have responded by developing outpatient departments that provide these services, but they face competition from freestanding ambulatory surgery centers. The prices for procedures provided in hospital outpatient departments are typically much higher than those charged in freestanding centers because of the hospitals' higher costs and stronger bargaining position with insurers. Medicare reimburses hospital-based outpatient procedures at rates substantially higher than those it pays freestanding ambulatory facilities. 1 The lower prices charged by freestanding ambulatory centers have stimulated interest among employers and insurers in encouraging employees and enrollees to select these facilities. Traditionally, however, consumers have been faced with insurance cost-sharing requirements that do not distinguish between facilities according to the prices charged. Surgical procedure prices exceed most patients' annual deductibles, and copayments do not vary by choice of facility. Payers are now experimenting with novel benefit designs that reward price-conscious consumer choice-for example, by requiring lower cost sharing from patients who select a low-price ambulatory center compared to those who select a high-price hospital outpatient department. Patients who need to use a hospital outpatient department because of special clinical needs or because their home is located in a remote geographic location are exempted from the costsharing initiatives.
In this article we examine the effect of reference-based benefits (RBB), a new health insurance design, on consumers' choices between hospital-based and freestanding surgical facilities. Under RBB designs, often called "referencebased pricing," the employer makes a fixed contribution toward payment for a procedure, with the patient paying the full difference between this contribution limit and the actual price charged by the facility. 2, 3 We assessed the impact of RBB on consumers' choices between an ambulatory surgical center and a hospital outpatient department for cataract surgery after adjusting for patient demographics, severity of illness, and the structure of local medical markets. We then analyzed changes in the total payments made by the employer and the employees, respectively, taking into account changes in facility choice.
Reference-Based Benefit Designs
RBB designs apply the principle of defined contribution, which traditionally has been applied to consumer choice among health insurance plans, to choice among hospitals, ambulatory facilities, and other providers that offer similar services but charge different prices. The employer or insurer establishes a contribution toward payment for each product or service, leaving the consumer to pay the difference between this contribution and the actual price charged by the provider.
RBB sometimes is used as an alternative to "narrow network" insurance designs in which the enrollee has no insurance coverage at all if using a high-price provider. It also can be combined with some versions of narrow network designs, as when the insurer imposes cost sharing for most services but exempts those obtained in a specially contracted "center of excellence," such as a provider with a national or global reputation for treating a specific condition. The relationship between RBB, narrow networks, and centers-of-excellence contracting has been discussed elsewhere. 4 Reference-based pricing is also a pharmaceutical purchasing strategy pursued by national insurers outside of the United States. These insurers base the maximum they are willing to reimburse for all drug products within one therapeutic class on the maximum price paid in another nation. 5, 6 In the United States, employers and insurers do not have the authority unilaterally to establish prices. Rather, they can establish benefit limits. Therefore, the term "referencebased benefits" rather than "reference-based pricing" is more appropriate for the US context.
The California Public Employees Retirement System (CalPERS) provides health insurance to 1.3 million employees of the State of California and other public entities, such as municipalities and school districts. Among the covered employees, approximately 450,000 are enrolled in the CalPERS self-insured preferred provider organization (PPO) option, managed by Anthem Blue Cross.
CalPERS originally implemented RBB for knee and hip replacement surgery. In 2009, prior to the implementation of RBB, CalPERS had been paying prices that ranged from approximately $20,000 to approximately $120,000, without evidence of quality differences. 4, 7 It established an RBB limit of $30,000 and initiated a communication program for its enrollees, indicating which hospitals charged prices below that limit and offered acceptable quality and geographic accessibility. In the first year after implementation, the share of orthopedic surgeries occurring in low-price hospitals increased by 21.2 percent. High-price hospitals reduced their prices by an average of 34.3 percent. CalPERS saved $2.8 million on these two orthopedic procedures, compared to what it would have spent in the absence of reference-based benefits. 8 In January 2012 CalPERS extended RBB to ambulatory surgery procedures because of the wide variation in prices across hospital outpatient departments and ambulatory surgery centers. It established the reference-based limits for hospital outpatient departments on the prices charged by ambulatory centers for the same procedures and continued to pay the centers their allowed charge. (The allowed charge is the rate negotiated by the insurer with and paid to the facility. The allowed charge is not the same as the facility's list price or charge-master price, which is rarely paid by insurers or enrollees.) Consumers who selected an ambulatory surgery center would not pay any RBB cost sharing, regardless of the price the center charged. However, consumers who selected a hospital outpatient department would pay the difference between the allowed charge of that department and the RBB limit.
This insurance design encouraged consumers to select ambulatory surgery centers instead of hospital outpatient departments because patients selecting the latter would be exposed to substantial cost sharing that did not count toward their out-of-pocket maximums. (CalPERS waived the RBB limit and paid the full hospital outpatient allowed charge if the patient's physician indicated medical reasons for choosing a hospital outpatient department or if the patient lived in a geographic region without easy access to an ambulatory center.)
Study Data And Methods
We obtained comprehensive claims data from CalPERS for all members undergoing cataract removal surgery between January 2009 and December 2013. We chose cataract surgery to study because it is a common and nonemergency procedure that is "shoppable," in the sense that consumers have time to assess alternative providers and travel to more distant facilities if they so choose. The data included three years of claims prior to and two years of claims post-implementation of reference-based benefits. For CalPERS, procedure volume ranged from 197 cases in 70 hospital outpatient departments and 467 cases in 104 ambulatory centers in 2009 to 108 cases in 38 hospital outpatient departments and 595 cases in 117 ambulatory centers in 2013.
The data included the allowed charge, the portion of that allowed charge paid by CalPERS, and the portion paid by the patient (through cost sharing and RBB provisions). The claims included an identifier for the facility where the procedure was performed and its ZIP code. These identifiers were used to categorize each facility as an ambulatory surgery center or hospital outpatient department and to assign to it a hospital market regional indicator, using the hospital referral regions identified by the Dartmouth Atlas of Health Care. We restricted the analysis to CalPERS enrollees ages 18-64 who lived in and received their procedures in California because reference-based benefits were restricted to that state. Measured characteristics of the patients included age, sex, and the diagnostic and procedure codes from all claims incurred for all purposes. These diagnostic and procedure codes were used to develop a measure of patient health status and comorbidities using the Charlson comorbidity index. 10 Patients in CalPERS who were exempted from the RBB initiative were excluded from the statistical analyses because their facility selection and payments could not be influenced by the initiative; 4 percent of such patients were exempted in 2012, and 7 percent were in 2013.
To control for determinants of consumer choice and spending other than RBB, we used as a control group non-CalPERS enrollees covered by Anthem Blue Cross who underwent cataract surgery during these five years in California and were not subject to RBB. (For the sake of simplicity, we refer to the RBB arm as "CalPERS" and the non-RBB arm as "Anthem.") The Anthem data were structured in a manner identical to the CalPERS data to facilitate comparisons. Descriptive statistics on the CalPERS and Anthem enrollees are presented in online Appendix We analyzed trends between 2009 and 2013 for three outcome variables: the probability that a patient selected an ambulatory center instead of a hospital outpatient department; the average price per procedure, which captures the combined impact of RBB on selection of ambulatory centers and of changes in ambulatory center and hospital outpatient prices; and trends in payments by CalPERS and cost-sharing obligations for individual CalPERS enrollees. These calculations took into account the changing financial responsibility between employer and employee for patients who selected a hospital outpatient department after implementation of RBB limits but were not exempted by CalPERS from the RBB initiative.
We then conducted multivariate difference-indifferences regressions using the CalPERS and Anthem populations during the five-year period. These regression analyses included four dependent variables: the probability that the consumer selected an ambulatory center (compared to a hospital outpatient department); the average price (allowed charge) for the procedure (including patients using an ambulatory surgery center and those using a hospital outpatient department); the total CalPERS payment per procedure, taking into consideration both price and volume; and consumer cost-sharing responsibility per procedure. Covariates included year, payer (CalPERS versus Anthem), interaction terms between year and payer, the Charlson comorbidity index, patient age categories, patient sex, and geographic hospital market indicators.
Payers are now experimenting with novel benefit designs that reward priceconscious consumer choice.
Study Results
Facility Prices And Consumers' Choices Exhibit 1 presents the distribution of prices charged for cataract removal surgery at hospital outpatient departments and ambulatory surgery centers in 2011, prior to implementation of RBB. Prices in the former ranged from $1,218 to $14,099, with a median of $6,546, while prices in the latter ranged from $1,009 to $8,658, with a median of $1,524. Exhibit 1 highlights differences in average prices between hospital-based and freestanding centers plus the price variability within each type of facility. It also shows the $2,000 RBB limit subsequently established by CalPERS. This contribution limit reflected approximately the seventieth percentile in the distribution of ambulatory surgery center prices. In 2011, 94 percent of hospital outpatient departments and 27 percent of ambulatory surgery centers charged prices above this contribution limit. Regression analyses of the association between RBB and ambulatory surgery center choice, controlling for age, sex, Charlson comorbidity score, and market characteristics, are presented in Appendix Table 2. 11 After adjustment for these factors, the 2013 shift by CalPERS to RBB was associated with an 8.6-percentagepoint increase in ambulatory center use compared to rates of use by Anthem enrollees. The regression-adjusted association between RBB and consumers' choice of ambulatory surgery centers thus is similar in magnitude to the unadjusted association depicted in Exhibit 2.
Impact On Prices And Spending Exhibit 3 shows trends in average prices paid per cataract surgery procedure between 2009 and 2013 for CalPERS and Anthem members, respectively. These trends capture the changing relative mix of ambulatory and hospital-based utilization, with the former charging substantially lower prices. In the years prior to implementation of RBB, average prices paid by CalPERS were higher than the average prices paid by Anthem members. This was largely because many CalPERS members were located in and around Sacramento, the state capital-a region in which consolidation of hospitals has fostered high prices. 12 The Anthem membership, on the other hand, was more broadly distributed across the state, with a large percentage living in the more competitive Los Angeles regional market.
In the year following implementation of RBB, the average price paid by CalPERS declined by 10.2 percent as a result of the shift by its mem- bers to lower-price ambulatory surgery centers. Average prices charged to Anthem enrollees not subject to RBB declined only slightly because they did not shift to ambulatory surgery centers at the same rate as did CalPERS members. In 2013 the average price paid per procedure by CalPERS was 8 percent below that paid by Anthem.
Appendix Table 2 11 presents multivariate regression results for the association between implementation of RBB and the average prices paid, after controlling for differences over time in patient demographics, disease severity, and market location. After these factors were controlled for, the average price fell by 17.9 percent for CalPERS members in 2013 compared to Anthem enrollees. The regression-adjusted association between RBB and prices thus is larger than the unadjusted association presented in Exhibit 3 (that is, RBB is found to have a stronger pricereducing effect after case-mix and market factors are controlled for).
Exhibit 4 presents trends in payments per procedure by CalPERS and Anthem plus trends in patient cost-sharing responsibilities. These figures take into account the changing use of ambulatory surgery centers and hospital outpatient facilities and the fact that a greater share of the total hospital-based payments were shifted from CalPERS to its members after 2011 if they did not meet clinical or geographic criteria for exemption.
In 2011, prior to the implementation of RBB limits, the average CalPERS payment per procedure was $2,751-16.6 percent higher than the $2,360 average payment by Anthem. Two years after implementation of RBB, CalPERS payments had declined by 38.5 percent. By 2013 the CalPERS payment was 25.4 percent below the Anthem rate.
Appendix Table 2 11 presents regression analyses of CalPERS and Anthem payments per procedure, accounting for patient and market factors in addition to the implementation of RBB. After adjustment for other factors, in 2013 CalPERS paid $1,019, which is equivalent to 45 percent less per procedure that it would have paid absent RBB. This regression-adjusted association is larger than the unadjusted association presented in Exhibit 4.
The multivariate regression analyses in Appendix Table 2 11 present the changes attributable to RBB in dollar as well as percentage terms, after adjustment for patient case-mix and other factors. CalPERS in 2012 paid $764 less per procedure than in 2011, prior to the RBB initiative. Payments continued to decrease in the second year after RBB implementation ($1,019 below 2011 levels). In the first two years after implementation of RBB, CalPERS saved $1.3 million on cataract surgery compared to what it would have spent in the absence of reference-based benefit design.
Impact On Consumer Financial Responsibility Under RBB designs such as the one implemented by CalPERS, individual patients are responsible for two forms of cost sharing. First, they must pay the amounts owed under their traditional deductible and coinsurance provisions, limited by the annual out-of-pocket maximum. The size of these cost-sharing require- ments depends on whether they select an ambulatory surgery center or hospital outpatient department. Second, patients are responsible for the difference between the RBB limit and the actual price negotiated by the hospital if they select a hospital outpatient department and are not otherwise exempted from the RBB limit as the result of clinical or geographic criteria. The difference between the RBB limit and the actual price is not subject to the annual out-ofpocket maximum.
The information in Exhibit 4 on consumers' financial responsibility presents data on CalPERS patients using an ambulatory surgery center, those using a hospital outpatient department but exempt from the RBB initiative, and those using a hospital-based facility but not exempt from the RBB initiative. The data in the exhibit thus underestimated the impact of RBB on the group of patients targeted by the initiative-those using a hospital-based facility but not exempt from RBB limits. In contrast, Exhibit 5 presents trends in cost-sharing obligations for three distinct categories of CalPERS members, according to whether they selected an ambulatory-or hospital-based facility and, for those selecting the latter, on whether or not they were exempted from the RBB initiative. The actual amounts paid by patients vary according to their choice of facility. They also differ according to how much the patients have incurred in cost sharing for services aside from cataract surgery, given that deductible and coinsurance provisions are limited by an annual out-of-pocket payment maximum.
As indicated in Exhibit 5, cost-sharing obligations for CalPERS patients were much lower if they selected an ambulatory surgery center rather than a hospital outpatient department. For the three years prior to implementation of RBB, cost sharing for hospital outpatients averaged 79 percent above the obligation incurred by ambulatory surgery center patients. For patients who were exempt from the RBB limits, this difference remained unchanged in the subsequent two years. However, financial responsibilities increased substantially in 2012 and 2013 for CalPERS patients selecting a hospital outpatient department while not exempted from the RBB limits. The average patient responsibility for nonexempt hospital outpatient users increased from $1,045 in 2011 to $4,918 in 2012 and to $5,681 in 2013.
Discussion
In recent years many employers have shifted from comprehensive benefit designs to highdeductible health plans that expose employees to greater out-of-pocket expenses for routine services. 13 Reference-based benefit designs extend these incentives to more expensive services such as inpatient and outpatient surgery. Implementation of RBB for pharmaceuticals in Europe has been associated with an average 11.5 percent reduction in drug prices and 14.0-52.0 percent reductions in insurer expenditures. 14 In the United States, the implementation of RBB for inpatient knee and hip replacement surgery was associated with a 28.0 percent increase in market share for lower-price hospitals, an overall 20.2 percent reduction in total payments per procedure, and a reduction in spending by $6 million over two years. 9 This study assessed the impact of RBB design on cataract removal surgery, where the patient faces a choice between a hospital-based outpatient department or a freestanding ambulatory surgery center. Prior to implementation of RBB in 2012, there were major price differences between the two types of facilities, as well as among the facilities themselves, as highlighted in Exhibit 1. The CalPERS initiative established a benefit limit for patients selecting a hospital outpatient department but continued to offer traditional coverage for patients who chose an ambulatory surgery facility.
It was to be expected that the RBB limit would increase the share of patients selecting an ambulatory center instead of a hospital outpatient department and consequently reduce employers' spending on these procedures. The empirical analysis produced results consistent with this hypothesis. It was also to be expected that consumers' financial responsibility would increase significantly for patients selecting a hospital outpatient facility after the implementation of RBB limits, unless the patients were exempted because their physician indicated a clinical reason or they lived in a rural area without access to an ambulatory center. The results were consistent with these expectations as well.
The available data do not permit insight into whether nonexempt CalPERS patients using a hospital outpatient department actually paid the cost-sharing amounts for which they became responsible after the implementation of the RBB initiative. Hospitals could waive cost sharing above the RBB limit in order not to lose patients to competing ambulatory surgery centers. It is possible that these patient responsibilities in fact were waived because hospital patients might be reluctant to pay $4,000 for cataract surgery when they could obtain the same procedure for much less money at a nearby ambulatory surgery center. If hospitals did waive the patient's responsibility, the RBB program would have instigated de facto price competition in the market for ambulatory surgery.
It should be emphasized that RBB has only modest potential to limit the overall rate of cost growth in health care because it is most logically applied to products and procedures that are discrete and can easily be priced and compared. To date, RBB has been applied to drugs; laboratory tests; diagnostic radiology procedures; scheduled orthopedic surgery; and, now, scheduled ambulatory surgery. It is not easily applicable to conditions requiring many different services, such as diabetes, or to procedures where there is a large and unmeasured variation in case-mix severity. Paul Fronstin and Christopher Roebuck estimate that RBB could save employers 1.6 percent of annual health care costs if applied to seven surgical and radiological procedures. 2 These procedures do not include ambulatory surgery, drugs, laboratory tests, or major procedures for which patients frequently travel to regional centers of excellence.
RBB design will exert sustained impacts on the use and price of health care services only if it is accompanied by complementary changes in the tools available to consumers when making choices. Consumers need price and quality information that is specific to the providers in their community as well as to their individual insurance plans. Health plans and independent data aggregators are beginning to fill this need, taking advantage of mobile health technology to bring transparency on price and quality to the patient at the time of the decision.
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Conclusion
Until recently, many consumers have been slow to use price data as part of their choice of providers, because they have lacked a financial incentive to do so. With the spread of high-deductible plans and reference-based benefit designs, however, consumers are increasingly facing those incentives. Together, new benefit designs and transparency tools lay the foundation for an increasingly consumer-driven health care system. ▪ RBB design will exert sustained impacts on the use and price of care only if it is accompanied by changes in the tools available to consumers when making choices.
